Innate Pharma

Company Description

---

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

Innate is a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

Year founded

---

1999

Served area

---

Worldwide

Headcount

---

215

Headquarters

---

117 Avenue de Luminy, 13009 Marseille – France

Shares outstanding

---

79,753,657

IPO

---

Oct. 31, 2006

Stock exchange(s)

---

Euronext Paris